BARD ASSOCIATES INC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 39 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARD ASSOCIATES INC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2020$44,000
-49.4%
124,100
-0.2%
0.03%
-27.3%
Q4 2019$87,000
-4.4%
124,300
-4.2%
0.04%
-4.3%
Q3 2019$91,000
-48.3%
129,775
-4.3%
0.05%
-47.7%
Q2 2019$176,000
-39.5%
135,575
-1.6%
0.09%
-40.1%
Q1 2019$291,000
-7.9%
137,800
-1.8%
0.15%
-19.7%
Q4 2018$316,000
-87.9%
140,300
-81.1%
0.18%
-23.8%
Q3 2018$2,605,000
+7.2%
744,000
-2.0%
0.24%
+6.2%
Q2 2018$2,430,000
+354.2%
759,000
+396.2%
0.23%
-15.4%
Q1 2018$535,000
-19.5%
152,950
+1.3%
0.27%
-16.3%
Q4 2017$665,000
-15.8%
151,050
-0.1%
0.32%
-13.3%
Q3 2017$790,000
-0.8%
151,250
-1.2%
0.37%
+1.9%
Q2 2017$796,000
-75.5%
153,050
-80.0%
0.36%
+19.5%
Q1 2017$3,250,000
+561.9%
765,250
+390.5%
0.30%
+32.5%
Q4 2016$491,000
-9.4%
156,000
-1.3%
0.23%
-14.0%
Q3 2016$542,000
+21.8%
158,000
-0.6%
0.26%
+12.3%
Q2 2016$445,000
-55.5%
159,000
-2.6%
0.24%
-59.1%
Q1 2016$1,001,000
+13.1%
163,250
-0.4%
0.58%
+10.5%
Q4 2015$885,000
+30.7%
163,975
-6.3%
0.52%
+33.8%
Q3 2015$677,000
-8.8%
174,925
-0.9%
0.39%
+6.0%
Q2 2015$742,000
+4.5%
176,575
-2.0%
0.37%
+8.2%
Q1 2015$710,000
-36.7%
180,175
-0.8%
0.34%
-35.1%
Q4 2014$1,121,000
+36.4%
181,675
+3.4%
0.52%
+36.1%
Q3 2014$822,000
-3.0%
175,675
-0.2%
0.38%
+14.9%
Q2 2014$847,000
-22.1%
176,075
+3.0%
0.34%
-27.2%
Q1 2014$1,087,000
-0.6%
170,9250.0%0.46%
+1.1%
Q4 2013$1,094,000170,9250.46%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders